Genomic Medicine Guidance: A Point-of-Care App for Heritable Thoracic Aortic Diseases.
Ontology highlight
ABSTRACT: Genetic testing can determine familial and personal risks for heritable thoracic aortic aneurysms and dissections (TAD). The 2022 ACC/AHA guidelines for TAD recommend management decisions based on the specific gene mutation. However, many clinicians lack sufficient comfort or insight to integrate genetic information into clinical practice. We therefore developed the Genomic Medicine Guidance (GMG) app, an interactive point-of care tool to inform clinicians and patients about TAD diagnosis, treatment, and surveillance. GMG is a REDCap-based app that combines publicly available genetic data and clinical recommendations based on the TAD guidelines into one translational education tool. TAD genetic information in GMG was sourced from the Montalcino Aortic Consortium, a worldwide collaboration
SUBMITTER: Patil R
PROVIDER: S-EPMC10793513 | biostudies-literature | 2023 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA